Sources

9 Total Sources

FDA Grants Daraxonrasib Access for Pancreatic Cancer After Survival Rose to 13 Months

The San Diego Union-Tribune1d ago

FDA Approves Daraxonrasib Expanded Access for Pancreatic Cancer After Doubling Survival

Revolution Medicines Changes Pancreatic Cancer Story with Daraxonrasib | OncoDaily posted on the topic | LinkedIn

A new pill called daraxonrasib is giving fresh hope to people with pancreatic cancer after nearly doubling survival in a major clinical trial. Read more at: https://www.firstpost.com/health/daraxonrasib-explained-the-experimental-pill-giving-new-hope ...

ActionNewsJax.com1d ago

Game-changing pill for pancreatic cancer, daraxonrasib , shows unprecedented results - Action News Jax

Instagram1d ago

A new pill called daraxonrasib is giving fresh hope to people with pancreatic cancer after nearly doubling survival in a major clinical trial. Unlike chemotherapy, it targets a common cancer mutation, making

Targeted Oncology1d ago

Dr Pant on the Landscape-Changing Success of Daraxonrasib in Pancreatic Cancer | Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways

Live 5 News WCSC1d ago

Unheard of': Trident doctor on new drug doubling pancreatic cancer survival

tiktok.com1d ago

Clinical trials of daraxonrasib, a new pancreatic cancer treatment, ha... | what cancers look like | TikTok

ASCO: Revolution poised to capture RAS space as pancreatic cancer dataset 'derisks' approval - BioSpace